Results 1 to 10 of about 3,989,493 (170)

In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy

open access: yesJournal of Animal Reproduction and Biotechnology, 2022
Currently, there is no treatment to reverse or cure heart failure caused by ischemic heart disease and myocardial infarction despite the remarkable advances in modern medicine.
Yun-Gwi Park   +3 more
doaj   +1 more source

Novel microRNAs modulating ecto-5′-nucleotidase expression

open access: yesFrontiers in Immunology, 2023
IntroductionThe expression of immune checkpoint molecules (ICMs) by cancer cells is known to counteract tumor-reactive immune responses, thereby promoting tumor immune escape.
Theresa Kordaß   +4 more
doaj   +1 more source

Characterization and reduction of non-endocrine cells accompanying islet-like endocrine cells differentiated from human iPSC

open access: yesScientific Reports, 2022
The differentiation of pancreatic endocrine cells from human pluripotent stem cells has been thoroughly investigated for their application in cell therapy against diabetes.
Hideyuki Hiyoshi   +10 more
doaj   +1 more source

Recent advances in edible coating of food products and its legislations: A review

open access: yesJournal of Agriculture and Food Research, 2023
Food products are highly perishable in nature which undergoes quick quality deterioration. In this note, the kind of packaging decides the active preservation of food qualities.
Krishna Priya   +2 more
doaj   +1 more source

ERRγ enhances cardiac maturation with T-tubule formation in human iPSC-derived cardiomyocytes

open access: yesNature Communications, 2021
Cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs) suffer from limited maturation. Here the authors identify ERRγ agonist as a factor that enhances cardiac morphological, metabolic, contractile and electrical maturation of ...
Kenji Miki   +20 more
doaj   +1 more source

T–cell anergy and peripheral T–cell tolerance [PDF]

open access: yesPhilosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 2001
The discovery that T–cell recognition of antigen can have distinct outcomes has advanced understanding of peripheral T–cell tolerance, and opened up new possibilities in immunotherapy. Anergy is one such outcome, and results from partial T–cell activation.
R, Lechler   +3 more
openaire   +2 more sources

A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

open access: yesNature Communications, 2021
T-cell immunotherapies, such as CAR-T immunotherapy, are being developed against a wide variety of diseases. Here the authors report the feeder-free, scalable differentiation of human induced pluripotent cells (iPSCs) to T-cells with T-cell receptor ...
Shoichi Iriguchi   +19 more
doaj   +1 more source

Donor T cells for CAR T cell therapy

open access: yesBiomarker Research, 2022
AbstractAdoptive cell therapy using patient-derived chimeric receptor antigen (CAR) T cells redirected against tumor cells has shown remarkable success in treating hematologic cancers. However, wider accessibility of cellular therapies for all patients is needed.
Tang, TCY   +5 more
openaire   +4 more sources

Chronic Inflammation Links Cancer and Parkinson’s disease

open access: yesFrontiers in Aging Neuroscience, 2016
An increasing number of genetic studies suggest that the pathogenesis of Parkinson’s disease (PD) and cancer share common genes, pathways, and mechanisms.
Zhiming eLi   +10 more
doaj   +1 more source

Downregulation of HMGB1 in thymoma cells affects T cell differentiation

open access: yesCentral European Journal of Immunology, 2023
Introduction: Thymoma is the most common anterior mediastinal tumor and is closely associated with myasthenia gravis (MG). Our previous study showed that the expression of Th17 cells increased and the expression of Treg decreased in MG-associated thymoma
Jian Li   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy